NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PUBLICATIONS

Immunomodulatory Effects of Macrolide Antibiotics in Sulfur Mustard Exposed Airway Epithelial Cells: Quantum Dots-Mediated Immunocytochemical Analysis of iNOS and Diaminofluorescein-Mediated Flow Cytometric Analysis of Intracellular Nitric Oxide

Published

Author(s)

X P. Gao, Radharaman Ray, Yan Xiao, Peter E. Barker, Prabhati Ray

Abstract

Exposure of airway epithelial cells to 100 uM sulfur mustard significantly upregulated induced nitric oxide (iNOS) in cells. This response, quantitated by both flow cytometry and quantum dot-visualized antibodies, is returned to normal iNOS levels if cells are pretreated with FDA-approved macrolide antibiotics roxithromycin, azithromycin, clarithromycin and erythromycin.
Citation
Journal of Histochemistry & Cytochemistry
Pub Type
Journals

Keywords

macrolide antibotics, quantum dot fluorophores, sulfur mustard

Citation

Gao, X. , Ray, R. , Xiao, Y. , Barker, P. and Ray, P. (2021), Immunomodulatory Effects of Macrolide Antibiotics in Sulfur Mustard Exposed Airway Epithelial Cells: Quantum Dots-Mediated Immunocytochemical Analysis of iNOS and Diaminofluorescein-Mediated Flow Cytometric Analysis of Intracellular Nitric Oxide, Journal of Histochemistry & Cytochemistry (Accessed October 14, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created October 12, 2021
Was this page helpful?